Colgate-Palmolive Company Stock Buy Recommendation Reiterated (CL)
NEW YORK (TheStreet) -- Colgate-Palmolive Company (NYSE:CL) has been reiterated by TheStreet Ratings as a buy with a ratings score of A+ . The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
- CL's revenue growth has slightly outpaced the industry average of 1.2%. Since the same quarter one year prior, revenues slightly increased by 2.0%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
- The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Household Products industry and the overall market, COLGATE-PALMOLIVE CO's return on equity significantly exceeds that of both the industry average and the S&P 500.
- The gross profit margin for COLGATE-PALMOLIVE CO is rather high; currently it is at 60.30%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 14.70% is above that of the industry average.
- Net operating cash flow has increased to $531.00 million or 12.02% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of -8.25%.
- COLGATE-PALMOLIVE CO's earnings per share improvement from the most recent quarter was slightly positive. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, COLGATE-PALMOLIVE CO increased its bottom line by earning $4.94 versus $4.31 in the prior year. This year, the market expects an improvement in earnings ($5.34 versus $4.94).
--Written by a member of TheStreet Ratings Staff. TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.
Latest Headlines about CL
-
Procter & Gamble: CEO Regression Comes at a Big Price
06:00AM 05/31/13
-
Cramer's 'Mad Money' Recap: Stop Being Complacent
08:17PM 05/29/13
-
Go Deep for Dividends, Viable Yields
08:51AM 05/28/13
-
A Look Back; Data; QE: Best of Kass
02:02PM 05/26/13
-
Cramer: Enough With the Hedge Fund Coverage
11:54AM 05/16/13
-
Cramer Quick Take: Looking for Dividend Champions
11:17AM 05/16/13
-
Cramer: Looks Like Europe May Have Hit Bottom
12:48PM 04/30/13
Latest from TheStreet Wire
-
Abbott Laboratories (ABT): Today's Featured Health Services Laggard
05:22PM 06/19/13
-
Petroleo Brasileiro SA Petrobras (PBR): Today's Featured Basic Materials Laggard
05:01PM 06/19/13
-
Microsoft Corporation (MSFT): Today's Featured Computer Software & Services Laggard
05:01PM 06/19/13
-
Target Corp (TGT): Today's Featured Services Laggard
05:01PM 06/19/13
-
Teck Resources Ltd (TCK): Today's Featured Metals & Mining Laggard
05:01PM 06/19/13
-
United Technologies Corp (UTX): Today's Featured Industrial Laggard
05:01PM 06/19/13
-
Texas Instruments Inc. (TXN): Today's Featured Electronics Laggard
05:01PM 06/19/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
